Literature DB >> 30785635

Blood pressure and hypertension.

Jason DeGuire1, Janine Clarke1, Kaitlyn Rouleau1, Joel Roy1, Tracey Bushnik2.   

Abstract

BACKGROUND: Hypertension, or high blood pressure, is a major cause of disability and the leading risk factor for death around the world. Ongoing surveillance is necessary to monitor and assess the population burden of hypertension in Canada. DATA AND METHODS: Using measured data from the Canadian Health Measures Survey, this analysis estimates average systolic blood pressure (BP), average diastolic BP, and hypertension prevalence, awareness, treatment and control in the population aged 20 to 79 years in the period from 2012 to 2015 by sex and age group. Crude and age-standardized overall estimates for 2007-2009, 2009-2011, 2012-2013 and 2014-2015 are also presented.
RESULTS: Among adults aged 20 to 79 years, 24% of males and 23% of females had hypertension, defined as measured BP ≥140/90 mm Hg or past-month use of antihypertensive medication. Hypertension prevalence increased to 40% for males and 32% for females when the BP threshold was lowered to ≥130/80 mm Hg. Among adults, 84% of people with hypertension were aware of their condition, 80% of hypertensive people were treated for their condition, and 66% had controlled hypertension (measured BP ⟨140/90 mm Hg), though those aged 20 to 39 were less likely than older age groups to be aware, treated or controlled. Crude and age-standardized rates remained fairly stable during the period from 2007-2009 to 2014-2015. DISCUSSION: Hypertension prevalence among adults has remained stable over time in Canada, and hypertension awareness, treatment and control have remained high. However, rates of awareness, treatment and control are lower among younger adults. This finding highlights the importance of initiatives to encourage this population to have their blood pressure checked and treated.

Entities:  

Keywords:  Blood pressure; awareness; control; hypertension; prevalence

Mesh:

Substances:

Year:  2019        PMID: 30785635

Source DB:  PubMed          Journal:  Health Rep        ISSN: 0840-6529            Impact factor:   4.796


  10 in total

1.  COVID-19 vaccination intention during early vaccine rollout in Canada: a nationwide online survey.

Authors:  Xuyang Tang; Hellen Gelband; Nico Nagelkerke; Isaac I Bogoch; Patrick Brown; Ed Morawski; Teresa Lam; Prabhat Jha
Journal:  Lancet Reg Health Am       Date:  2021-08-27

2.  Evaluation of the cardioprotective and antihypertensive effect of AVE 0991 in normotensive and hypertensive rats.

Authors:  Matheus Vinicius Barbosa da Silva; Célio Pereira de Sousa Júnior; Heverton Valentim Colaço da Silva; Vanessa Maria Dos Santos; Francisco Israel Magalhães Feijao; Amanda de Oliveira Bernardino; José Augusto Calafell Roig Tiburcio de Melo
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-07       Impact factor: 1.712

3.  Prevalence and Associated Factors of Hypertension among Women in Southern Ghana: Evidence from 2014 GDHS.

Authors:  Cyprian Issahaku Dorgbetor; Kwamena Sekyi Dickson; Edward Kwabena Ameyaw; Kenneth Setorwu Adde
Journal:  Int J Hypertens       Date:  2022-06-20       Impact factor: 2.434

4.  Predictors of cardiovascular diseases among people living with HIV initiated on antiretroviral therapy in Khomas region, Namibia: A cross-sectional study.

Authors:  Roswitha Mahalie; Penehafo Angula; Kabwebwe Honoré Mitonga; Olanrewaju Oladimeji
Journal:  J Public Health Afr       Date:  2022-05-24

5.  Hypertension prevalence, awareness, treatment and control in 2019 in the adult population of Mayotte.

Authors:  Lucinda Calas; Marion Subiros; Marc Ruello; Youssouf Hassani; Amélie Gabet; Marion Angue; Odile Pointeau; Valérie Olié; Clémence Grave
Journal:  Eur J Public Health       Date:  2022-06-01       Impact factor: 4.424

6.  A data quality assessment to inform hypertension surveillance using primary care electronic medical record data from Alberta, Canada.

Authors:  Stephanie Garies; Kerry McBrien; Hude Quan; Donna Manca; Neil Drummond; Tyler Williamson
Journal:  BMC Public Health       Date:  2021-02-02       Impact factor: 3.295

7.  Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults.

Authors:  Xuyang Tang; Abha Sharma; Maria Pasic; Patrick Brown; Karen Colwill; Hellen Gelband; H Chaim Birnboim; Nico Nagelkerke; Isaac I Bogoch; Aiyush Bansal; Leslie Newcombe; Justin Slater; Peter S Rodriguez; Guowen Huang; Sze Hang Fu; Catherine Meh; Daphne C Wu; Rupert Kaul; Marc-André Langlois; Ed Morawski; Andy Hollander; Demetre Eliopoulos; Benjamin Aloi; Teresa Lam; Kento T Abe; Bhavisha Rathod; Mahya Fazel-Zarandi; Jenny Wang; Mariam Iskilova; Adrian Pasculescu; Lauren Caldwell; Miriam Barrios-Rodiles; Zahraa Mohammed-Ali; Nandita Vas; Divya Raman Santhanam; Eo Rin Cho; Kathleen Qu; Shreya Jha; Vedika Jha; Wilson Suraweera; Varsha Malhotra; Kathy Mastali; Richard Wen; Samir Sinha; Angus Reid; Anne-Claude Gingras; Pranesh Chakraborty; Arthur S Slutsky; Prabhat Jha
Journal:  JAMA Netw Open       Date:  2022-02-01

8.  Spatiotemporal Analysis of the Prevalence and Pattern of Multimorbidity in Older Chinese Adults.

Authors:  Shimin Chen; Shengshu Wang; Wangping Jia; Ke Han; Yang Song; Shaohua Liu; Xuehang Li; Miao Liu; Yao He
Journal:  Front Med (Lausanne)       Date:  2022-01-20

9.  Prevalence of isolated diastolic hypertension and the risk of cardiovascular mortality among adults aged 40 years and older in northeast China: a prospective cohort study.

Authors:  Ling Yue; Hongyun Chen; Qun Sun; Lei Shi; Jixu Sun; Guangxiao Li; Liying Xing; Shuang Liu
Journal:  BMJ Open       Date:  2022-09-17       Impact factor: 3.006

10.  Patterns of hypertension management in France in 2015: The ESTEBAN survey.

Authors:  Alexandre Vallée; Amélie Gabet; Clémence Grave; Emmanuel Sorbets; Jacques Blacher; Valérie Olié
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-24       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.